Capmaxen 200 Mg (Capmatinib) – 56 Tablets

Capmaxen 200 Mg (Capmatinib) represents a significant advancement in the treatment of advanced lung cancer. The active ingredient, Capmatinib, is a potent and selective MET inhibitor, offering targeted therapy for individuals with specific genetic mutations driving the progression of lung cancer.

Capmaxen 200 mg relies on Capmatinib, a member of the MET inhibitor class. Its mechanism of action involves blocking the activity of the MET receptor, which plays a crucial role in cancer cell growth, survival, and metastasis.

Capmaxen (Capmatinib) is primarily employed for the treatment of:

• Non-Small Cell Lung Cancer (NSCLC): Capmatinib is prescribed for individuals with metastatic NSCLC whose tumors harbor specific genetic mutations, including MET exon 14 skipping mutations.

Product Feature:

You will have the ability to order easily and pay the best price if you use Unit Pharmacy Website for buying Capmaxen 200 Mg (Capmatinib) medicine.